Metis Global Partners LLC lifted its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 15.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 133,190 shares of the company's stock after acquiring an additional 17,581 shares during the period. Procter & Gamble makes up approximately 0.6% of Metis Global Partners LLC's portfolio, making the stock its 25th biggest position. Metis Global Partners LLC's holdings in Procter & Gamble were worth $22,698,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in PG. Cladis Investment Advisory LLC boosted its stake in Procter & Gamble by 5.2% during the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares during the last quarter. FAS Wealth Partners Inc. boosted its stake in shares of Procter & Gamble by 2.0% in the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock worth $4,642,000 after buying an additional 549 shares during the last quarter. Capital Investment Advisory Services LLC boosted its stake in shares of Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after buying an additional 4,562 shares during the last quarter. World Investment Advisors boosted its stake in shares of Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after buying an additional 2,886 shares during the last quarter. Finally, Yoffe Investment Management LLC purchased a new position in shares of Procter & Gamble in the 4th quarter worth approximately $1,874,000. 65.77% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on the company. Erste Group Bank downgraded Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Morgan Stanley set a $180.00 price target on shares of Procter & Gamble and gave the stock an "overweight" rating in a report on Friday, April 25th. Wells Fargo & Company lowered their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday. Barclays set a $164.00 target price on shares of Procter & Gamble in a report on Thursday. Finally, Piper Sandler boosted their target price on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. Nine research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $175.88.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction on Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the transaction, the insider owned 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.18% of the company's stock.
Procter & Gamble Stock Down 1.1%
NYSE PG traded down $1.70 during mid-day trading on Thursday, reaching $151.18. The stock had a trading volume of 6,220,871 shares, compared to its average volume of 8,225,136. Procter & Gamble Company has a 1 year low of $150.16 and a 1 year high of $180.43. The stock has a market cap of $354.46 billion, a PE ratio of 23.22, a price-to-earnings-growth ratio of 4.47 and a beta of 0.40. The company has a fifty day moving average price of $160.43 and a 200 day moving average price of $164.11. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.70 and a quick ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.56%. The firm's revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.40 EPS. On average, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date is Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 67.14%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.